Legacy Education Announces Five-Year ACCET Reaccreditation for Contra Costa Medical Career College, Reinforcing Academic Quality
Legacy Education (NYSE American: LGCY) announced that Contra Costa Medical Career College received a five-year reaccreditation from the Accrediting Council for Continuing Education & Training (ACCET) on April 30, 2026.
Rhea-AI Summary
Legacy Education (NYSE American: LGCY) announced that Contra Costa Medical Career College received a five-year reaccreditation from the Accrediting Council for Continuing Education & Training (ACCET) on April 30, 2026. The decision recognizes academic oversight, student outcomes, and institutional operations, and supports the college's stability and ability to scale healthcare programs.
Positive
- Five-year ACCET reaccreditation granted to Contra Costa Medical Career College
- Reaccreditation covers academic oversight, student outcomes, and operations
- Validates integration of the college as Legacy's most recent acquisition
- Supports ability to scale healthcare programs aligned with workforce demand
Negative
- None.
Details
News Market Reaction – LGCY
In the Apr 30 session, LGCY declined 3.81%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Reaccreditation term
- five-year grant
- ACCET reaccreditation for Contra Costa Medical Career College
Historical Context
-
Participation in 38th Annual ROTH Conference with investor meetings.
-
Six-year reaccreditation for Integrity College of Health from ABHES.
-
Strong Q2 FY2026 revenue, enrollment, EBITDA and net income growth.
-
Appointment of SVP of Operations to manage scalable multi-campus growth.
-
Announcement of date and access details for Q2 earnings release call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
reaccreditation regulatory
accrediting council for continuing education & training regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
The reaccreditation decision follows ACCET's comprehensive review and recognizes CCMCC's performance across academic oversight, student outcomes, and institutional operations. The five-year term reflects sustained alignment with national standards and reinforces the college's position as a high-quality career education provider.
Receiving the maximum reaccreditation term highlights CCMCC's ability to deliver consistent outcomes while maintaining disciplined compliance and operational execution. The result supports the long-term stability of the institution and its ability to scale programs aligned with workforce demand in healthcare.
"Achieving the full five-year reaccreditation from ACCET is an important milestone for Contra Costa Medical Career College, particularly as our most recent acquisition," said LeeAnn Rohmann, Chief Executive Officer of Legacy Education. "This outcome validates both the strength of the institution and our disciplined approach to integrating and growing high-quality assets that deliver strong student outcomes and long-term value."
About Contra Costa Medical Career College
Contra Costa Medical Career College is located in
ABOUT LEGACY EDUCATION
Legacy Education (NYSE: LGCY) is an award-winning, nationally accredited, for-profit post-secondary education company founded in 2009. Legacy Education provides career-focused education primarily in the healthcare field, with certificates and degrees for nursing, sonography, medical technicians, dental assisting, business administration, and several others. The Company offers a wide range of educational programs and services to help students achieve their professional goals. Legacy Education's focus is on providing high-quality education that is accessible and affordable. Legacy Education is committed to growing its education footprint via organic enrollment growth, addition of new programs, and accretive acquisitions. For more information, please visit www.legacyed.com or on LinkedIn @legacy-education-inc.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the Company's operations. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Actual results may differ materially from those indicated by these forward-looking statements because of various important factors, including, without limitation, market conditions and the factors described in the section entitled "Risk Factors" in Legacy's most recent Annual Report on Form 10-K and Legacy's other filings made with the
Contact Legacy Education Inc.
Investor Relations
ir@legacyed.com
Amato and Partners, LLC
Investors Relations Counsel
admin@amatoandpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/legacy-education-announces-five-year-accet-reaccreditation-for-contra-costa-medical-career-college-reinforcing-academic-quality-302758628.html
SOURCE Legacy Education Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.